Benitec Biopharma

Benitec Biopharma BNTC Stock

$8.54   -5.530970%
Add to favorites
Market Cap
$297.95M
LOW - HIGH [24H]
$8.51 - $9.30
VOLUME [24H]
$133.36K
P/E Ratio
0
Earnings per share
-$0.98
ISIN
US08205P2092
Price   Prediction

Benitec Biopharma Price Chart

Sorry, that's all we've gotfor now...

Benitec Biopharma (BNTC) stock price today is 8.54 USD on Tech Market Small (-5.53% on the day). Updated .

Benitec Biopharma BNTC Financial and Trading Overview

Benitec Biopharma stock price 8.54 USD
Previous Close 9.09 USD
Open 9.17 USD
Bid 6.35 USD x 200
Ask 11.39 USD x 200
Day's Range 8.69 - 9.3 USD
52 Week Range 7.89 - 14.39 USD
Volume 144.69K USD
Avg. Volume 177.19K USD
Market Cap 315.4M USD
Beta (5Y Monthly) 0.236
PE Ratio (TTM) N/A
EPS (TTM) -0.98 USD
Forward Dividend & Yield N/A (0%)
Ex-Dividend Date N/A
1y Target Est 23.32 USD

BNTC Valuation Measures

Enterprise Value 150.79M USD
Trailing P/E N/A
Forward P/E -0.9596603
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) N/A
Price/Book (mrq) 1.8593172
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -2.702

Trading Information

Benitec Biopharma Stock Price History

Beta (5Y Monthly) 0.236
52-Week Change -33.18%
S&P500 52-Week Change 13.32%
52 Week High 14.39 USD
52 Week Low 7.89 USD
50-Day Moving Average 9.67 USD
200-Day Moving Average 11.38 USD

BNTC Share Statistics

Avg. Volume (3 month) 177.19K USD
Avg. Daily Volume (10-Days) 211.15K USD
Shares Outstanding 34.89M
Float 20.52M
Short Ratio 10.61
% Held by Insiders 0.54%
% Held by Institutions 96.18%
Shares Short 1.99M
Short % of Float 15.22%
Short % of Shares Outstanding 5.71%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor 1:17

Financial Highlights

Fiscal Year

Fiscal Year Ends June 30, 2026
Most Recent Quarter (mrq) September 30, 2026
Next Fiscal Year End June 30, 2027

Profitability

Profit Margin 0%
Operating Margin (ttm) 0%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -25.38%
Return on Equity (ttm) -37.61%

Income Statement

Revenue (ttm) N/A
Revenue Per Share (ttm) N/A
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) N/A
EBITDA -55804000 USD
Net Income Avi to Common (ttm) -49506000 USD
Diluted EPS (ttm) -0.98
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 176.37M USD
Total Cash Per Share (mrq) 4.88 USD
Total Debt (mrq) 642K USD
Total Debt/Equity (mrq) 0.38 USD
Current Ratio (mrq) 19.621
Book Value Per Share (mrq) 4.862

Cash Flow Statement

Operating Cash Flow (ttm) -16790000 USD
Levered Free Cash Flow (ttm) -1972250 USD

Profile of Benitec Biopharma

Country United States
State CA
City Hayward
Address 3940 Trust Way
ZIP 94545
Phone 510 780 0819
Website https://benitec.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 24

Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines in the United States. Its Silence and Replace, a DNA-directedRNA interference platform, that combines RNA interference with gene therapy to create medicines which simultaneously facilitate sustained silencing of disease-causing genes and concomitant delivery of wildtype replacement genes following a single administration of the therapeutic construct. The company is developing BB-301, an AAV-based gene therapy designed to silence the expression of the disease-causing gene, which is in phase 1b/2a for the treatment of oculopharyngeal muscular dystrophy related dysphagia. Benitec Biopharma Inc. is headquartered in Hayward, California.

Q&A For Benitec Biopharma Stock

What is a current BNTC stock price?

Benitec Biopharma BNTC stock price today per share is 8.54 USD.

How to purchase Benitec Biopharma stock?

You can buy BNTC shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Benitec Biopharma?

The stock symbol or ticker of Benitec Biopharma is BNTC.

Which industry does the Benitec Biopharma company belong to?

The Benitec Biopharma industry is Biotechnology.

How many shares does Benitec Biopharma have in circulation?

The max supply of Benitec Biopharma shares is 34.89M.

What is Benitec Biopharma Price to Earnings Ratio (PE Ratio)?

Benitec Biopharma PE Ratio is now.

What was Benitec Biopharma earnings per share over the trailing 12 months (TTM)?

Benitec Biopharma EPS is -0.98 USD over the trailing 12 months.

Which sector does the Benitec Biopharma company belong to?

The Benitec Biopharma sector is Healthcare.

Benitec Biopharma BNTC included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
us US Tech Composite IXIC US 24509.76 USD —
-2.49
8.22B USD — 24460.28 USD — 24882.04 USD — — 8.22B USD —
us US Tech Composite Total Return XCMP US 30288.13 USD —
-2.49
— — 30226.99 USD — 30748.16 USD — — — —
us US Tech Capital Market Composite RCMP US 109.8 USD —
-2.87
— — 109.67 USD — 111.73 USD — — — —
us US Tech Health Care IXHC US 1342.75 USD —
-1.87
— — 1340.49 USD — 1374 USD — — — —
$2.21T
Total marketcap
$75.27B
Total volume
BTC 58.54%   •   ETH 10.01%
Dominance
Select currency